The Latest Headlines at The Lincolnian Online
Fifth Era Acquisition Corp I (NASDAQ:FERAU) Shares Up 0.7% – Here’s What Happened
Fifth Era Acquisition Corp I (NASDAQ:FERAU – Get Free Report) was up 0.7% on Thursday . The stock traded as high as $10.58 and last traded at $10.58. Approximately 300 shares changed hands during trading, a decline of 76% from... More of this article »
First Trust Energy AlphaDEX Fund (NYSEARCA:FXN) Short Interest Up 79.5% in February
First Trust Energy AlphaDEX Fund (NYSEARCA:FXN – Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 13th, there was short interest totaling 106,784 shares, an... More of this article »
Neuberger Berman Small-Mid Cap ETF (NYSEARCA:NBSM) Sees Significant Increase in Short Interest
Neuberger Berman Small-Mid Cap ETF (NYSEARCA:NBSM – Get Free Report) saw a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 7,794 shares, an increase of 81.2%... More of this article »
Crown Crafts (NASDAQ:CRWS) Stock Price Passes Above 200 Day Moving Average – What’s Next?
Crown Crafts, Inc. (NASDAQ:CRWS – Get Free Report)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.87 and traded as high as... More of this article »
RPGL (NASDAQ:RPGL) Shares Down 25.6% – Time to Sell?
RPGL (NASDAQ:RPGL – Get Free Report)’s share price dropped 25.6% during mid-day trading on Thursday . The company traded as low as $4.00 and last traded at $4.09. Approximately 247,651 shares traded hands during mid-day... More of this article »
Chenghe Acquisition III (NASDAQ:CHECW) Shares Down 8% – Here’s Why
Chenghe Acquisition III Co. (NASDAQ:CHECW – Get Free Report) fell 8% during trading on Thursday . The company traded as low as $0.23 and last traded at $0.23. 17,500 shares changed hands during mid-day trading, an increase of... More of this article »-ltd-logo-1200x675.png?v=20260217064403&w=240&h=220&zc=2){kind=logo}
Cuprina Holdings (Cayman) (NASDAQ:CUPR) Stock Price Up 2.3% – Here’s Why
Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR – Get Free Report)’s share price rose 2.3% during mid-day trading on Thursday . The stock traded as high as $0.3950 and last traded at $0.3850. Approximately 111,868 shares were... More of this article »
YieldMax GOOGL Option Income Strategy ETF (NYSEARCA:GOOY) Short Interest Update
YieldMax GOOGL Option Income Strategy ETF (NYSEARCA:GOOY – Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 347,600 shares,... More of this article »
SPDR S&P Fossil Fuel Reserves Free ETF (NYSEARCA:SPYX) Short Interest Up 82.4% in February
SPDR S&P Fossil Fuel Reserves Free ETF (NYSEARCA:SPYX – Get Free Report) saw a large increase in short interest in February. As of February 13th, there was short interest totaling 40,658 shares, an increase of 82.4% from... More of this article »
Trade Desk Q4 Earnings Call Highlights
Trade Desk (NASDAQ:TTD) executives highlighted a year of record revenue, continued profitability, and a slate of AI-driven product initiatives while acknowledging persistent budget pressure in consumer packaged goods (CPG) and automotive... More of this article »
PLDT Q4 Earnings Call Highlights
PLDT (NYSE:PHI) reported full-year 2025 results showing modest revenue growth, stable profitability, lower capital spending, and a swing to full-year profitability at its fintech unit Maya, according to management’s remarks during... More of this article »
Mid Cap Stocks Worth Watching – February 28th
ProShares UltraPro Short QQQ, Applied Optoelectronics, and Duolingo are the three Mid Cap stocks to watch today, according to MarketBeat’s stock screener tool. Mid-cap stocks are shares of publicly traded companies whose market... More of this article »
Sarepta Therapeutics Q4 Earnings Call Highlights
Sarepta Therapeutics (NASDAQ:SRPT) executives used the company’s fourth-quarter 2025 earnings call to highlight a stronger balance sheet, stable demand for its exon-skipping therapies, and a renewed commercial push for its gene... More of this article »